Burleson R L, Jones D B, Yenikomshian A, DeVoe C, DeRito J
Transplant Proc. 1977 Sep;9(3):1591-6.
Simultaneous double renal allografts were performed in 32 dogs to evaluate the effect of pretreatment of the donor kidney with either Medrol, cytoxan, and methotrexate or medrol and procarbazine. There was no prolongation of survival of treated allografts. Immunosuppressive therapy for the transplanted animal unmasked a pretreatment injury of the pretreated kidney. Treatment of an autograft kidney in an intermediate host produced a cytotoxic tubular lesion in the kidney and also appeared to protect the kidney from the double ischemic insult incurred during the transplantation procedure. Pretreatment of dog donors of renal allografts with cytotoxic agents thereby offers no immunologic advantage for graft survival and produces a cytotoxic tubular lesion that is detrimental to kidney survival when ischemic and immunologic injury is minimal.
对32只狗进行了同期双肾移植,以评估用甲泼尼龙、环磷酰胺和甲氨蝶呤或甲泼尼龙和丙卡巴肼对供肾进行预处理的效果。经处理的同种异体移植物的存活时间没有延长。对移植动物的免疫抑制治疗揭示了预处理肾脏的预处理损伤。在中间宿主中对自体移植肾进行处理会在肾脏中产生细胞毒性肾小管病变,并且似乎还能保护肾脏免受移植过程中发生的双重缺血性损伤。因此,用细胞毒性药物对肾同种异体移植的狗供体进行预处理对移植物存活没有免疫优势,并且会产生细胞毒性肾小管病变,当缺血和免疫损伤很小时,这种病变对肾脏存活是有害的。